Incidence and Clinical Characteristics of Colonic and Extra Colonic Lynch Syndrome Manifestations in Uruguayan Mismatch Repair Carriers
Journal Title: Colorectal Cancer: Open Access - Year 2017, Vol 3, Issue 1
Abstract
Background: Colon cancer is a frequent diagnosis worldwide affecting both men and women. Lynch syndrome in an autosomal dominant inheritable condition, accountable for 5 to 7% of colon cancer, as well as other malignancies. Methodology: From a Uruguayan high risk cancer clinical setting, adult probands from 115 families, registered between 2015 and 2016, meeting Amsterdam I, II or Bethesda Revised guidelines, were tested for MMR genes and EPCAM. Results: Pathogenic Lynch Syndrome mutations were detected in 23.4% families. A total of 90 mutation carriers were diagnosed, from which information regarding molecular diagnosis, cancer diagnosis, cancer site, tumor staging, age at diagnosis and course of treatment was carefully analyzed. Cancer diagnosis before determination of carrier status was seen in 52.5% individuals; were 46.8% had more than one cancer diagnosis throughout lifetime, mostly colon cancer. The average age for colon cancer was 36.9 years old and 77% were stage II at diagnosis. Consequently, surgical treatment was the most frequent option, and partial colectomies the preferred surgical choice. Conclusions: Young age of onset and metachronous tumors are part of Lynch syndrome hallmark. How effective surveillance strategies are, are reflected on how well and timely we identify these young high risk adults. Treatment options are most frequently surgical ones, because of the stage these malignant tumors are found upon diagnosis. There is no unanimous consensus about the best surgical strategy for colon cancer Lynch syndrome carriers.
Authors and Affiliations
Florencia N
Keywords
Related Articles
- EP ID EP311252
- DOI 10.21767/2471-9943.100036
- Views 105
- Downloads 0
Updates on the Molecular Genetics of Colorectal Cancer
Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. Although definitive therapies for advanced disease are still lacking, rapid progress has been made in the last decade in understanding the molecul...
CDX2 - A Predictive Biomarker in Stage II Colon Cancer for Adjuvant Chemotherapy?
In the United States, colorectal cancer (CRC) is the third most common cancer among men and women. Estimated new cases were 134,490 in 2016, which was 8% of all new cancer cases, while 49,190 deaths were expected [1]. Th...
Screening is the Most Effective Preventive Measure against Colorectal Cancer
According to the American Cancer Society, an estimated 135,430 people will be diagnosed with colon cancer in 2017 alone. There’s no denying how much of a problem colorectal cancer has become, but what many people don’t r...
Umbilical Stoma: A Classical but New Concept
Today, surgeons almost always create a stoma through a left or right rectus muscle-splitting incision to avoid placement at the midline laparotomy wound of patients. In the past, some surgeons preferred to create a colos...
Nicotine Modifies Cytokine Production by Human Mononuclears Stimulated by Colon Cancer Cells
Background: The undesirable effects of prolonged tobacco use and cigarette smoking are well-known and are due to inhalation of a great number of alkaloids including nicotine. Lung cancer is the most feared ailment in chr...